NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment (Q34088808)

30 July 2017

1 reference

title

NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment (English)

1 reference

30 July 2017

1 reference

Bours V

1

1 reference

30 July 2017

Bonizzi G

2

1 reference

30 July 2017

Bentires-Alj M

3

1 reference

30 July 2017

Bureau F

4

1 reference

30 July 2017

Piette J

5

1 reference

30 July 2017

Lekeux P

6

1 reference

30 July 2017

Merville M

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

30 July 2017

12

1 reference

inferred from page(s)

published in

Toxicology

1 reference

30 July 2017

153

1 reference

30 July 2017

1-3

1 reference

30 July 2017

27-38

1 reference

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Activate NF-kappa B or die?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

NF-kB: a pivotal role in asthma and a new target for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Expression of relB is required for the development of thymic medulla and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-kappa b in rat lung: inhibition by corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Isoleukotrienes are biologically active free radical products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Activation and localization of transcription factor, nuclear factor-kappaB, in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Activation of human immunodeficiency virus type 1 by oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Signal transduction through NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Identification and characterization of an IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Low levels of reactive oxygen species as modulators of cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

The pathogenesis of chronic obstructive pulmonary disease of horses

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Transcriptional cross talk between NF-kappaB and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2800%2900302-4

7 January 2021

10.1016/S0300-483X(00)00302-4

Identifiers

DOI

1 reference

30 July 2017

1 reference